Mezzion Pharma Co.Ltd Cash Flow Reinvestment Rate

Latest as of September 2023: 2.33x

Mezzion Pharma Co.Ltd cash flow reinvestment rate. Mezzion Pharma Co.Ltd (140410) has a Cash Flow Reinvestment Rate of 2.33x as of September 2023, reinvesting ₩11.01 Billion (capex ₩5.46 Billion plus investments ₩-5.55 Billion) from operating cash flow of ₩4.73 Billion. See Mezzion Pharma Co.Ltd (140410) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

2.33x

(Capex + Investments) / Operating CF

Total Reinvested

₩11.01 Billion

Capex + Investments

Operating Cash Flow

₩4.73 Billion

KRW

Capital Expenditures

₩5.46 Billion

KRW

Cash Flow Reinvestment Rate of Mezzion Pharma Co.Ltd (2012–2015)

Cash flow reinvestment rate of Mezzion Pharma Co.Ltd from 2012 to 2015. Historical reinvestment intensity for Mezzion Pharma Co.Ltd across 2 annual periods. Explore Mezzion Pharma Co.Ltd (140410) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Mezzion Pharma Co.Ltd Cash Flow Reinvestment Rate by Year (2012–2015)

Mezzion Pharma Co.Ltd cash flow reinvestment rate by year from 2012 to 2015. Year-by-year capital reinvestment analysis for Mezzion Pharma Co.Ltd. For the full cash flow conversion analysis, see how efficiently does Mezzion Pharma Co.Ltd generate cash.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2015	0.55x	₩983.20 Million	₩1.77 Billion	₩564.10 Million	▲ +77.0%
2012	0.31x	₩983.20 Million	₩3.14 Billion	₩564.10 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow